Product Information
TOVIAZ ER 4 MG TABLET is a brand product labeled by Pfizer Inc., priced at $9.2578 per EA under NDC 00069024230. Its NADAC has been published 657 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the fesoterodine fumarate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
4 mg/1
Manufacturer
Pfizer Inc.NDC
00069024230
Classification
Brand
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FESOTERODINE FUMARATEApproval Type
New Drug (NDA)
FDA Application
NDA022030On Market Since
10/31/2008
Price Statistics
The NADAC for TOVIAZ ER 4 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 70.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.2578 per EA |
|---|---|
| All-time high | $12.0342 (Nov 29, 2023) |
| All-time low | $5.4232 (Nov 28, 2013) |
| 52-week high | $9.2834 |
| 52-week low | $9.2561 |
| Median price | $9.5259 |
| Average price | $9.6679 |
| Largest weekly change | -23.0% (Dec 6, 2023) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 91% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TOVIAZ ER 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TOVIAZ ER 4 MG TABLET, manufactured by Pfizer Inc., is $9.2578 per EA (NDC 00069024230), effective Jun 24, 2026.
How has the price of TOVIAZ ER 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for TOVIAZ ER 4 MG TABLET has risen 70.7%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TOVIAZ ER 4 MG TABLET?
Since Nov 28, 2013, the NADAC for TOVIAZ ER 4 MG TABLET has ranged from a low of $5.4232 (Nov 28, 2013) to a high of $12.0342 (Nov 29, 2023), with a median of $9.5259 per EA.
Are there cheaper alternatives to TOVIAZ ER 4 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, FESOTERODINE ER 4 MG TABLET, is $0.8333 per EA — about 91% below TOVIAZ ER 4 MG TABLET.
Who manufactures TOVIAZ ER 4 MG TABLET?
TOVIAZ ER 4 MG TABLET (NDC 00069024230) is labeled by Pfizer Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification